Skip to main content

Carter Laura's Form 4/A amendment

Amended

Gossamer Bio, Inc. (GOSS) · filed Oct 27, 2022

Accession no.
0001728117-22-000094
Filed
Oct 27, 2022
Trade date
Oct 24, 2022
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Oct 25, 2022

This filing lists 1 non-derivative transaction. Open-market sales total $58.9K. It was filed 3 days after the trade.

This amendment replaces 0001728117-22-000090 (filed Oct 25, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Carter LauraCIK 0001858178Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2022Common StockSSaleDisposed−4,876$12.07F3−$58,853.3282,292Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Reporting Person's purchase of 6,934 shares of common stock at a price of $7.21 per share on July 15, 2022 was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the Reporting Person's sale of common stock reported herein and, to the extent of 2,058 shares, the Reporting Person's sale of common stock at a price of $8.278 per share on March 16, 2022. The Reporting Person has agreed top pay to the Issuer $18,558.51, which, together with the $7,351.42 previously paid to the Issuer on July 15, 2022, represents the full amount of the profit realized in connection with the short-swing transaction.

F2

Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

F3

This transaction was executed in multiple trades at prices ranging from $11.881 to $12.078 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold.Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Referenced by the price of 1 transaction in Table I.

Remarks

This Form 4 is being amended solely to add new footnote 1 regarding the reporting persons' prior agreement to disgorge short-swing profits to the Issuer.

Read the full filing on SEC EDGAR (opens in a new tab)